Triamcinolone and Metastatic neoplasm - a phase IV clinical study of FDA data

Summary:

Metastatic neoplasm is reported as a side effect among people who take Triamcinolone (triamcinolone), especially for people who are male, 50-59 old, also take Lovenox, and have Metastases to bone.

The phase IV clinical study analyzes which people have Metastatic neoplasm when taking Triamcinolone. It is created by eHealthMe based on reports of 25,490 people who have side effects when taking Triamcinolone from the FDA, and is updated regularly.

What is Triamcinolone?

Triamcinolone has active ingredients of triamcinolone. eHealthMe is studying from 25,577 Triamcinolone users. Check the latest studies of Triamcinolone.

What is Metastatic neoplasm?

Metastatic neoplasm (spreadable cancer tumour) is found to be associated with 602 drugs and 516 conditions by eHealthMe. Check the latest studies of Metastatic neoplasm.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

25,490 people reported to have side effects when taking Triamcinolone.
Among them, 21 people (0.08%) have Metastatic neoplasm.

Could Triamcinolone cause Metastatic neoplasm?

Among these 21 people:

What is the gender of people who have Metastatic neoplasm when taking Triamcinolone? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Metastatic neoplasm when taking Triamcinolone? *

What are other drugs people take besides Triamcinolone? *

What are other side effects people have besides Metastatic neoplasm? *

Osteoarthritis (a joint disease caused by cartilage loss in a joint): 18 people, 85.71%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 17 people, 80.95%
Joint Pain: 16 people, 76.19%
Bone Disorder: 16 people, 76.19%
Pain In Jaw: 16 people, 76.19%
Dental Caries: 14 people, 66.67%
Sinus Disorder (disease of sinus): 13 people, 61.90%
Impaired Healing: 12 people, 57.14%
Fungal Infection: 12 people, 57.14%
Anaemia (lack of blood): 12 people, 57.14%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 16 people, 76.19%
Pain: 9 people, 42.86%
Breast Cancer: 7 people, 33.33%
Anaemia (lack of blood): 7 people, 33.33%
Osteoporosis (bones weak and more likely to break): 2 people, 9.52%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 9.52%
Erythrodermic Psoriasis (generalized redness of the skin): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Triamcinolone and have Metastatic neoplasm?

- Check whether Metastatic neoplasm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triamcinolone:

Triamcinolone (25,577 reports)

Browse all side effects of Triamcinolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastatic neoplasm:

Metastatic neoplasm (602 drugs)

Browse all the conditions that are associated with Metastatic neoplasm:

Metastatic neoplasm (516 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone (the active ingredients of Triamcinolone) and Triamcinolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.